UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
7.38
2.24 (43.58%)
At close: Jun 06, 2025, 3:59 PM
7.55
2.37%
After-hours: Jun 06, 2025, 05:59 PM EDT

UroGen Pharma Statistics

Share Statistics

UroGen Pharma has 46.11M shares outstanding. The number of shares has increased by 12.07% in one year.

46.11M
12.07%
9.23%
84.16%
n/a
1,336
0.11%

Short Selling Information

The latest short interest is 5.59M, so 12.12% of the outstanding shares have been sold short.

5.59M
12.12%
12.37%
8.16

Valuation Ratios

The PE ratio is -3.6 and the forward PE ratio is -4.01. UroGen Pharma's PEG ratio is 0.22.

-3.6
-4.01
5.05
0.4
-51.87
-4.7
0.22
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for UroGen Pharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.01, with a Debt / Equity ratio of -14.02.

6.01
5.81
-14.02
-1.12
-1.27
-7.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$386,316.24
$-542,196.58
234
0.32
0.96

Taxes

2.83M
-2.28%

Stock Price Statistics

The stock price has increased by -61.11% in the last 52 weeks. The beta is 0.4, so UroGen Pharma's price volatility has been higher than the market average.

0.4
-61.11%
8.98
11.09
36.25
1,265,946

Income Statement

In the last 12 months, UroGen Pharma had revenue of 90.4M and earned -126.87M in profits. Earnings per share was -2.96.

90.4M
81.52M
-96.78M
-126.87M
-110.33M
-111.52M
-2.96
Full Income Statement

Balance Sheet

The company has 171.99M in cash and 123.39M in debt, giving a net cash position of 48.6M.

171.99M
123.39M
48.6M
-806.22M
247.62M
195.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -96.77M and capital expenditures -295K, giving a free cash flow of -97.06M.

-96.77M
-295K
-97.06M
-2.26
Full Cash Flow Statement

Margins

Gross margin is 90.18%, with operating and profit margins of -107.06% and -140.35%.

90.18%
-107.06%
-137.22%
-140.35%
-122.05%
-107.06%
-107.37%

Dividends & Yields

URGN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for URGN is $20, which is 289.9% higher than the current price. The consensus rating is "Buy".

$20
289.9%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.48
1